AVALON PHARMACEUTICALS INC·4

Oct 4, 6:08 PM ET

AVALON PHARMACEUTICALS INC 4

4 · AVALON PHARMACEUTICALS INC · Filed Oct 4, 2006

Insider Transaction Report

Form 4
Period: 2006-10-02
Transactions
  • Award

    Common Stock

    2006-10-02$2.57/sh+2,675$6,8757,571 total
Holdings
  • Common Stock

    (indirect: See footnote)
    757,138
Footnotes (2)
  • [F1]Issued in lieu of cash payment of director fees pursuant to Company's Stock Election Policy for Non-employee Director Fees.
  • [F2]Raymond J. Whitaker is a general partner of EuclidSR Partners, L.P. The reported securities are directly held by EuclidSR Partners, L.P. and EuclidSR Biotechnology Partners, L.P. The reporting person on this Form 4 disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION